|Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association|
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ...
circulation 127 (1), 143-152, 2013
|Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association|
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), 434-441, 2015
|Heart disease and stroke statistics-2017 update: a report from the American Heart Association.|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, J Floyd, ...
Circulation 135 (10), e146-e603, 2017
|Clinical guidelines for the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report|
National Institutes of Health
Obes Res 6 (2), 51S-209S, 1998
|Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and …|
P Poirier, TD Giles, GA Bray, Y Hong, JS Stern, FX Pi-Sunyer, RH Eckel
Circulation 113 (6), 898-918, 2006
|2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on …|
MD Jensen, DH Ryan, CM Apovian, JD Ard, AG Comuzzie, KA Donato, ...
Journal of the American college of cardiology 63 (25 Part B), 2985-3023, 2014
|10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study|
Diabetes Prevention Program Research Group
The Lancet 374 (9702), 1677-1686, 2009
|American heart association statistics committee and stroke statistics subcommittee|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
|Medical hazards of obesity|
Annals of internal medicine 119 (7_Part_2), 655-660, 1993
|Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial|
FX Pi-Sunyer, LJ Aronne, HM Heshmati, J Devin, J Rosenstock, ...
Jama 295 (7), 761-775, 2006
|The obesity epidemic: pathophysiology and consequences of obesity|
Obesity research 10 (S12), 97S-104S, 2002
|Health implications of obesity|
The American journal of clinical nutrition 53 (6), 1595S-1603S, 1991
|Comparisons of waist circumferences measured at 4 sites|
J Wang, JC Thornton, S Bari, B Williamson, D Gallagher, SB Heymsfield, ...
The American journal of clinical nutrition 77 (2), 379-384, 2003
|C-terminal octapeptide of cholecystokinin decreases food intake in man|
HR Kissileff, FX Pi-Sunyer, J Thornton, GP Smith
The American journal of clinical nutrition 34 (2), 154-160, 1981
|Weight loss with self-help compared with a structured commercial program: a randomized trial|
S Heshka, JW Anderson, RL Atkinson, FL Greenway, JO Hill, SD Phinney, ...
Jama 289 (14), 1792-1798, 2003
|Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association|
NF Sheard, NG Clark, JC Brand-Miller, MJ Franz, FX Pi-Sunyer, ...
Diabetes care 27 (9), 2266-2271, 2004
|Glycemic index and disease|
The American journal of clinical nutrition 76 (1), 290S-298S, 2002
|Weight stability masks sarcopenia in elderly men and women|
D Gallagher, E Ruts, M Visser, S Heshka, RN Baumgartner, J Wang, ...
American Journal of Physiology-Endocrinology And Metabolism 279 (2), E366-E375, 2000
|Association of an intensive lifestyle intervention with remission of type 2 diabetes|
EW Gregg, H Chen, LE Wagenknecht, JM Clark, LM Delahanty, J Bantle, ...
Jama 308 (23), 2489-2496, 2012
|Handbook of Obesity--Volume 1: Epidemiology, Etiology, and Physiopathology|
CRC Press, 2014